Global In-Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030

2024

Global In-Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030

Name: Global In-Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95000382
Price: 3450 USD
Availability: InStock
Rating: 5 (26.65 reviews)

In-Vitro Diagnostics, valued at US$ 102.85 billion in 2023, are forecasted to reach US$ 146.53 billion by 2030, with a 5.2% CAGR due to increasing demand in the downstream market.

Bonafide Trust
04-01-2024
Pages : 145
Figures : 85
Tables : 153
Region : Global
Category : Lifescience & Healthcare
Healthcare

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

According to Publisher’s latest study, the global In-Vitro Diagnostics market size was valued at US$ 102850 million in 2023. With the growing demand in the downstream market, In-Vitro Diagnostics is forecast to a readjusted size of US$ 146530 million by 2030 with a CAGR of 5.2% during the review period.

The research report highlights the growth potential of the global In-Vitro Diagnostics market. In-Vitro Diagnostics is expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimisation remain crucial for the widespread adoption of In-Vitro Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalise on the immense opportunities presented by the In-Vitro Diagnostics market. In-vitro diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagents.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Key Features:

The report on the In-Vitro Diagnostics market reflects various aspects and provides valuable insights into the industry.

Market Size and Growth: The research report provides an overview of the current size and growth of the In-Vitro Diagnostics market. It may include historical data, market segmentation by Type (e.g., Tissue Diagnostics, Professional Diagnostic), and regional breakdowns.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Market Drivers: Growing Disease Burden: The need for diagnostic testing and screening techniques is driven by the rising incidence of infectious outbreaks, chronic diseases, and ailments connected to lifestyle choices. The demand for early illness identification and proactive management is expanding due to ageing populations and changing epidemiological trends, which is driving the development of IVD technology. Technological Developments: The field of IVD is undergoing a revolution thanks to developments in biomarker identification, genomics, proteomics, and digital health technologies. Improved sensitivity, specificity, and multiplexing capabilities of advanced diagnostic platforms allow for quick and precise diagnosis in a variety of disease areas. Transition to customized Medicine: The need for companion diagnostics, pharmacogenomic testing, and molecular profiling services is being driven by the paradigm change towards customized medicine and precision diagnostics. Clinical practice paradigms are reshaped by IVD technologies, which are essential in directing treatment decisions, optimizing therapeutic outcomes, and avoiding adverse effects.

Challenges: Exorbitant Instrument Costs to Limit Market Expansion in Developing Nations
Over the past ten years, there have been major changes and enhancements in in-vitro diagnostics goods concerning additional design improvements. However, the high expenses of these instruments and their upkeep limited the market's expansion in some ways. Additionally, only qualified specialists are permitted to use in vitro diagnostics equipment. Additionally, this raises the devices' maintenance costs, which eventually hinders the market's overall growth.

Regulatory Obstacles: Compulsory regulations that differ by location make it difficult to enter a market and get a product approved. For market participants, navigating intricate regulatory frameworks, gaining required certifications, and guaranteeing adherence to quality standards are crucial factors.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Cost Containment Pressures: The need to prove the clinical utility and cost-effectiveness of IVD technologies is growing as healthcare systems struggle with rising expenses and tight budgets. Market participants must match their strategy for product pricing with the value judgments of healthcare stakeholders and outcomes-based reimbursement schemes.

Data Privacy and Security Issues: As digital health solutions and connected medical equipment proliferate, data privacy, security lapses, and regulatory compliance become more pressing problems. Building confidence and promoting the adoption of IVD technology requires securing patient health information, guaranteeing interoperability, and abiding by data protection laws.

Technological Developments: The research report can delve into the latest technological developments in the In-Vitro Diagnostics industry. This includes advancements in In-Vitro Diagnostics technology, In-Vitro Diagnostics new entrants, In-Vitro Diagnostics new investment, and other innovations that are shaping the future of In-Vitro Diagnostics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the In-Vitro Diagnostics market. It includes factors influencing customers' purchasing decisions, and preferences for In-Vitro Diagnostics products.

Government Policies and Incentives: The research report analyses the impact of government policies and incentives on the In-Vitro Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting the In-Vitro Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assesses the environmental impact and sustainability aspects of the In-Vitro Diagnostics market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provides market forecasts and outlook for the In-Vitro Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report concludes with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalise on emerging trends, overcome challenges, and contribute to the growth and development of the In-Vitro Diagnostics market.

Recent developments- NeoGenomics, Inc. is a prominent provider of oncology testing and global contract research services. In March 2023, the company announced that multiple next-generation sequencing (NGS) tests, including Neo Comprehensive - Solid Tumor, a comprehensive genomic profile (CGP) for solid tumour cancers, and Neo Comprehensive - Myeloid Disorders, a CGP for myeloid neoplasms, would be made commercially available.

Market Segmentation:

The In-vitro diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
1. Segmentation by type
• Tissue Diagnostics
• Professional Diagnostic
• Molecular Diagnostic
• Diabetes Monitoring
• Other
2. Segmentation by application
• Diabetes
• Infectious Diseases
• Oncology
• Cardiology
• HIV
• Other

Regional Insights: The market size for in vitro diagnostics is examined in America, Europe, Asia-Pacific, and Middle East and Africa. The in vitro diagnostics market was dominated by America, which is predicted to continue to be so for the duration of the market prediction.
In vitro diagnostics is predicted to grow at the fastest rate in Asia-Pacific during the forecast period. The presence of populated countries with strong purchasing power, like China and India, is responsible for the rise of the market in this region. Additionally, the market is growing due to the increased demand for personalized treatment and the use of high-tech processing to enhance the manufacture of in vitro diagnostic products. Due to the region's established domestic business presence and expanding industrial infrastructure, Asia-Pacific presents a lucrative opportunity for major players in the in vitro diagnostics market. As a result, it is expected to grow at the fastest rate during the forecast period. In addition, a major factor propelling the IVD market in the Asia-Pacific region is the rise in the prevalence of chronic illnesses including diabetes, heart disease, and cancer. For these disorders to be identified early on, managed, and monitored, diagnostic testing is essential.
America dominates the market which occupies 41.39% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, occupying 15.74% of the whole market.

3. Americas
• United States
• Canada
• Mexico
• Brazil
4. APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
5. Europe
• Germany
• France
• UK
• Italy
• Russia
6. Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape: The concentration of the market is relatively high, and the top 10 companies include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Becton Dickinson, BioMerieux, Sysmex, Hologic, Ortho Clinical Diagnostics, they occupied about 70% of the whole market. The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
• Roche
• Abbott
• Danaher
• Siemens Healthineers
• Thermo Fisher Scientific
• Sysmex
• BioMerieux
• Ortho Clinical Diagnostics
• Becton Dickinson
• Bio-Rad Laboratories
• Hologic
• LifeScan
• Qiagen
• Wuhan Easy Diagnosis
• Wondfo
• KHB
• Hotgen
• Mindray
• Sinocare
• Getein Biotech

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global In-Vitro Diagnostics Market Size 2019-2030
2.1.2 In-Vitro Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 In-Vitro Diagnostics Segment by Type
2.2.1 Tissue Diagnostics
2.2.2 Professional Diagnostic
2.2.3 Molecular Diagnostic
2.2.4 Diabetes Monitoring
2.2.5 Other
2.3 In-Vitro Diagnostics Market Size by Type
2.3.1 In-Vitro Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global In-Vitro Diagnostics Market Size Market Share by Type (2019-2024)
2.4 In-Vitro Diagnostics Segment by Application
2.4.1 Diabetes
2.4.2 Infectious Diseases
2.4.3 Oncology
2.4.4 Cardiology
2.4.5 HIV
2.4.6 Other
2.5 In-Vitro Diagnostics Market Size by Application
2.5.1 In-Vitro Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global In-Vitro Diagnostics Market Size Market Share by Application (2019-2024)
3 In-Vitro Diagnostics Market Size by Player
3.1 In-Vitro Diagnostics Market Size Market Share by Players
3.1.1 Global In-Vitro Diagnostics Revenue by Players (2019-2024)
3.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global In-Vitro Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 In-Vitro Diagnostics by Regions
4.1 In-Vitro Diagnostics Market Size by Regions (2019-2024)
4.2 Americas In-Vitro Diagnostics Market Size Growth (2019-2024)
4.3 APAC In-Vitro Diagnostics Market Size Growth (2019-2024)
4.4 Europe In-Vitro Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa In-Vitro Diagnostics Market Size Growth (2019-2024)
5 Americas
5.1 Americas In-Vitro Diagnostics Market Size by Country (2019-2024)
5.2 Americas In-Vitro Diagnostics Market Size by Type (2019-2024)
5.3 Americas In-Vitro Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC In-Vitro Diagnostics Market Size by Region (2019-2024)
6.2 APAC In-Vitro Diagnostics Market Size by Type (2019-2024)
6.3 APAC In-Vitro Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe In-Vitro Diagnostics by Country (2019-2024)
7.2 Europe In-Vitro Diagnostics Market Size by Type (2019-2024)
7.3 Europe In-Vitro Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa In-Vitro Diagnostics by Region (2019-2024)
8.2 Middle East & Africa In-Vitro Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa In-Vitro Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global In-Vitro Diagnostics Market Forecast
10.1 Global In-Vitro Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global In-Vitro Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas In-Vitro Diagnostics Forecast
10.1.3 APAC In-Vitro Diagnostics Forecast
10.1.4 Europe In-Vitro Diagnostics Forecast
10.1.5 Middle East & Africa In-Vitro Diagnostics Forecast
10.2 Americas In-Vitro Diagnostics Forecast by Country (2025-2030)
10.2.1 United States In-Vitro Diagnostics Market Forecast
10.2.2 Canada In-Vitro Diagnostics Market Forecast
10.2.3 Mexico In-Vitro Diagnostics Market Forecast
10.2.4 Brazil In-Vitro Diagnostics Market Forecast
10.3 APAC In-Vitro Diagnostics Forecast by Region (2025-2030)
10.3.1 China In-Vitro Diagnostics Market Forecast
10.3.2 Japan In-Vitro Diagnostics Market Forecast
10.3.3 Korea In-Vitro Diagnostics Market Forecast
10.3.4 Southeast Asia In-Vitro Diagnostics Market Forecast
10.3.5 India In-Vitro Diagnostics Market Forecast
10.3.6 Australia In-Vitro Diagnostics Market Forecast
10.4 Europe In-Vitro Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany In-Vitro Diagnostics Market Forecast
10.4.2 France In-Vitro Diagnostics Market Forecast
10.4.3 UK In-Vitro Diagnostics Market Forecast
10.4.4 Italy In-Vitro Diagnostics Market Forecast
10.4.5 Russia In-Vitro Diagnostics Market Forecast
10.5 Middle East & Africa In-Vitro Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt In-Vitro Diagnostics Market Forecast
10.5.2 South Africa In-Vitro Diagnostics Market Forecast
10.5.3 Israel In-Vitro Diagnostics Market Forecast
10.5.4 Turkey In-Vitro Diagnostics Market Forecast
10.5.5 GCC Countries In-Vitro Diagnostics Market Forecast
10.6 Global In-Vitro Diagnostics Forecast by Type (2025-2030)
10.7 Global In-Vitro Diagnostics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche In-Vitro Diagnostics Product Offered
11.1.3 Roche In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott In-Vitro Diagnostics Product Offered
11.2.3 Abbott In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abbott Main Business Overview
11.2.5 Abbott Latest Developments
11.3 Danaher
11.3.1 Danaher Company Information
11.3.2 Danaher In-Vitro Diagnostics Product Offered
11.3.3 Danaher In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Danaher Main Business Overview
11.3.5 Danaher Latest Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Information
11.4.2 Siemens Healthineers In-Vitro Diagnostics Product Offered
11.4.3 Siemens Healthineers In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Siemens Healthineers Main Business Overview
11.4.5 Siemens Healthineers Latest Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information
11.5.2 Thermo Fisher Scientific In-Vitro Diagnostics Product Offered
11.5.3 Thermo Fisher Scientific In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Thermo Fisher Scientific Main Business Overview
11.5.5 Thermo Fisher Scientific Latest Developments
11.6 Sysmex
11.6.1 Sysmex Company Information
11.6.2 Sysmex In-Vitro Diagnostics Product Offered
11.6.3 Sysmex In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sysmex Main Business Overview
11.6.5 Sysmex Latest Developments
11.7 BioMerieux
11.7.1 BioMerieux Company Information
11.7.2 BioMerieux In-Vitro Diagnostics Product Offered
11.7.3 BioMerieux In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 BioMerieux Main Business Overview
11.7.5 BioMerieux Latest Developments
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Information
11.8.2 Ortho Clinical Diagnostics In-Vitro Diagnostics Product Offered
11.8.3 Ortho Clinical Diagnostics In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Ortho Clinical Diagnostics Main Business Overview
11.8.5 Ortho Clinical Diagnostics Latest Developments
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Information
11.9.2 Becton Dickinson In-Vitro Diagnostics Product Offered
11.9.3 Becton Dickinson In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Becton Dickinson Main Business Overview
11.9.5 Becton Dickinson Latest Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Information
11.10.2 Bio-Rad Laboratories In-Vitro Diagnostics Product Offered
11.10.3 Bio-Rad Laboratories In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bio-Rad Laboratories Main Business Overview
11.10.5 Bio-Rad Laboratories Latest Developments
11.11 Hologic
11.11.1 Hologic Company Information
11.11.2 Hologic In-Vitro Diagnostics Product Offered
11.11.3 Hologic In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Hologic Main Business Overview
11.11.5 Hologic Latest Developments
11.12 LifeScan
11.12.1 LifeScan Company Information
11.12.2 LifeScan In-Vitro Diagnostics Product Offered
11.12.3 LifeScan In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 LifeScan Main Business Overview
11.12.5 LifeScan Latest Developments
11.13 Qiagen
11.13.1 Qiagen Company Information
11.13.2 Qiagen In-Vitro Diagnostics Product Offered
11.13.3 Qiagen In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Qiagen Main Business Overview
11.13.5 Qiagen Latest Developments
11.14 Wuhan Easy Diagnosis
11.14.1 Wuhan Easy Diagnosis Company Information
11.14.2 Wuhan Easy Diagnosis In-Vitro Diagnostics Product Offered
11.14.3 Wuhan Easy Diagnosis In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Wuhan Easy Diagnosis Main Business Overview
11.14.5 Wuhan Easy Diagnosis Latest Developments
11.15 Wondfo
11.15.1 Wondfo Company Information
11.15.2 Wondfo In-Vitro Diagnostics Product Offered
11.15.3 Wondfo In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Wondfo Main Business Overview
11.15.5 Wondfo Latest Developments
11.16 KHB
11.16.1 KHB Company Information
11.16.2 KHB In-Vitro Diagnostics Product Offered
11.16.3 KHB In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 KHB Main Business Overview
11.16.5 KHB Latest Developments
11.17 Hotgen
11.17.1 Hotgen Company Information
11.17.2 Hotgen In-Vitro Diagnostics Product Offered
11.17.3 Hotgen In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Hotgen Main Business Overview
11.17.5 Hotgen Latest Developments
11.18 Mindray
11.18.1 Mindray Company Information
11.18.2 Mindray In-Vitro Diagnostics Product Offered
11.18.3 Mindray In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Mindray Main Business Overview
11.18.5 Mindray Latest Developments
11.19 Sinocare
11.19.1 Sinocare Company Information
11.19.2 Sinocare In-Vitro Diagnostics Product Offered
11.19.3 Sinocare In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Sinocare Main Business Overview
11.19.5 Sinocare Latest Developments
11.20 Getein Biotech
11.20.1 Getein Biotech Company Information
11.20.2 Getein Biotech In-Vitro Diagnostics Product Offered
11.20.3 Getein Biotech In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Getein Biotech Main Business Overview
11.20.5 Getein Biotech Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. In-Vitro Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Tissue Diagnostics
Table 3. Major Players of Professional Diagnostic
Table 4. Major Players of Molecular Diagnostic
Table 5. Major Players of Diabetes Monitoring
Table 6. Major Players of Other
Table 7. In-Vitro Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global In-Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global In-Vitro Diagnostics Market Size Market Share by Type (2019-2024)
Table 10. In-Vitro Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global In-Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global In-Vitro Diagnostics Market Size Market Share by Application (2019-2024)
Table 13. Global In-Vitro Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global In-Vitro Diagnostics Revenue Market Share by Player (2019-2024)
Table 15. In-Vitro Diagnostics Key Players Head office and Products Offered
Table 16. In-Vitro Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global In-Vitro Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global In-Vitro Diagnostics Market Size Market Share by Regions (2019-2024)
Table 21. Global In-Vitro Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global In-Vitro Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas In-Vitro Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas In-Vitro Diagnostics Market Size Market Share by Country (2019-2024)
Table 25. Americas In-Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas In-Vitro Diagnostics Market Size Market Share by Type (2019-2024)
Table 27. Americas In-Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas In-Vitro Diagnostics Market Size Market Share by Application (2019-2024)
Table 29. APAC In-Vitro Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC In-Vitro Diagnostics Market Size Market Share by Region (2019-2024)
Table 31. APAC In-Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC In-Vitro Diagnostics Market Size Market Share by Type (2019-2024)
Table 33. APAC In-Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC In-Vitro Diagnostics Market Size Market Share by Application (2019-2024)
Table 35. Europe In-Vitro Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe In-Vitro Diagnostics Market Size Market Share by Country (2019-2024)
Table 37. Europe In-Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe In-Vitro Diagnostics Market Size Market Share by Type (2019-2024)
Table 39. Europe In-Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe In-Vitro Diagnostics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa In-Vitro Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa In-Vitro Diagnostics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa In-Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa In-Vitro Diagnostics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa In-Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa In-Vitro Diagnostics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of In-Vitro Diagnostics
Table 48. Key Market Challenges & Risks of In-Vitro Diagnostics
Table 49. Key Industry Trends of In-Vitro Diagnostics
Table 50. Global In-Vitro Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global In-Vitro Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global In-Vitro Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global In-Vitro Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Roche Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 55. Roche In-Vitro Diagnostics Product Offered
Table 56. Roche In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Abbott Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 60. Abbott In-Vitro Diagnostics Product Offered
Table 61. Abbott Main Business
Table 62. Abbott In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Abbott Latest Developments
Table 64. Danaher Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 65. Danaher In-Vitro Diagnostics Product Offered
Table 66. Danaher Main Business
Table 67. Danaher In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Danaher Latest Developments
Table 69. Siemens Healthineers Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 70. Siemens Healthineers In-Vitro Diagnostics Product Offered
Table 71. Siemens Healthineers Main Business
Table 72. Siemens Healthineers In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Siemens Healthineers Latest Developments
Table 74. Thermo Fisher Scientific Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 75. Thermo Fisher Scientific In-Vitro Diagnostics Product Offered
Table 76. Thermo Fisher Scientific Main Business
Table 77. Thermo Fisher Scientific In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Thermo Fisher Scientific Latest Developments
Table 79. Sysmex Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 80. Sysmex In-Vitro Diagnostics Product Offered
Table 81. Sysmex Main Business
Table 82. Sysmex In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Sysmex Latest Developments
Table 84. BioMerieux Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 85. BioMerieux In-Vitro Diagnostics Product Offered
Table 86. BioMerieux Main Business
Table 87. BioMerieux In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. BioMerieux Latest Developments
Table 89. Ortho Clinical Diagnostics Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 90. Ortho Clinical Diagnostics In-Vitro Diagnostics Product Offered
Table 91. Ortho Clinical Diagnostics Main Business
Table 92. Ortho Clinical Diagnostics In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Ortho Clinical Diagnostics Latest Developments
Table 94. Becton Dickinson Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 95. Becton Dickinson In-Vitro Diagnostics Product Offered
Table 96. Becton Dickinson Main Business
Table 97. Becton Dickinson In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Becton Dickinson Latest Developments
Table 99. Bio-Rad Laboratories Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 100. Bio-Rad Laboratories In-Vitro Diagnostics Product Offered
Table 101. Bio-Rad Laboratories Main Business
Table 102. Bio-Rad Laboratories In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Bio-Rad Laboratories Latest Developments
Table 104. Hologic Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 105. Hologic In-Vitro Diagnostics Product Offered
Table 106. Hologic In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Hologic Main Business
Table 108. Hologic Latest Developments
Table 109. LifeScan Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 110. LifeScan In-Vitro Diagnostics Product Offered
Table 111. LifeScan Main Business
Table 112. LifeScan In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. LifeScan Latest Developments
Table 114. Qiagen Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 115. Qiagen In-Vitro Diagnostics Product Offered
Table 116. Qiagen Main Business
Table 117. Qiagen In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Qiagen Latest Developments
Table 119. Wuhan Easy Diagnosis Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 120. Wuhan Easy Diagnosis In-Vitro Diagnostics Product Offered
Table 121. Wuhan Easy Diagnosis Main Business
Table 122. Wuhan Easy Diagnosis In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Wuhan Easy Diagnosis Latest Developments
Table 124. Wondfo Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 125. Wondfo In-Vitro Diagnostics Product Offered
Table 126. Wondfo Main Business
Table 127. Wondfo In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Wondfo Latest Developments
Table 129. KHB Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 130. KHB In-Vitro Diagnostics Product Offered
Table 131. KHB Main Business
Table 132. KHB In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. KHB Latest Developments
Table 134. Hotgen Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 135. Hotgen In-Vitro Diagnostics Product Offered
Table 136. Hotgen Main Business
Table 137. Hotgen In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Hotgen Latest Developments
Table 139. Mindray Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 140. Mindray In-Vitro Diagnostics Product Offered
Table 141. Mindray Main Business
Table 142. Mindray In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Mindray Latest Developments
Table 144. Sinocare Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 145. Sinocare In-Vitro Diagnostics Product Offered
Table 146. Sinocare Main Business
Table 147. Sinocare In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Sinocare Latest Developments
Table 149. Getein Biotech Details, Company Type, In-Vitro Diagnostics Area Served and Its Competitors
Table 150. Getein Biotech In-Vitro Diagnostics Product Offered
Table 151. Getein Biotech Main Business
Table 152. Getein Biotech In-Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Getein Biotech Latest Developments

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted